HOOD vs NMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

HOOD

64.9
AI Score
VS
HOOD Wins

NMR

64.5
AI Score

Investment Advisor Scores

HOOD

65score
Recommendation
BUY

NMR

65score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HOOD NMR Winner
Revenue 1.09B 10.45B NMR
Net Income -1.95B -368.00M NMR
Net Margin -179.1% -3.5% NMR
ROE 98.1% -1.4% HOOD
ROA -10.8% -0.1% NMR
Total Assets 18.09B 479.44B NMR
Cash 5.08B 7.16B NMR

Relative Price Performance (Last 90 Days)

HOOD 1M: -18.0% · 3M: +0.3% NMR 1M: -7.4% · 3M: -5.6%

Current Technical Phase

HOOD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.6 · Price: $101.93

NMR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 33

RSI (14): 33.0 · Price: $9.22

Fundamentals Snapshot

Metric HOOD NMR
Market Cap — —
Forward P/E 34.6 12.4
Trailing P/E 43.3 10.6
Revenue (TTM) — —
Revenue Growth 0.3% 0.3%
Gross Margin 0.9% 0.8%
Operating Margin 0.4% 0.3%
EPS 2.27 0.86
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, HOOD is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.